The current institutional shareholding score of Ascendis Pharma A/S is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 111.42%, representing a quarter-over-quarter decrease of 4.32%. The largest institutional shareholder is ETHSX, holding a total of 132.15K shares, representing 0.22% of shares outstanding, with 450.00% increase in holdings.